Core Viewpoint - The animal health sector experienced a slight increase of 0.89% on November 14, with *ST Green Kang leading the gains, while the overall market indices, including the Shanghai Composite Index and Shenzhen Component Index, saw declines of 0.97% and 1.93% respectively [1] Group 1: Market Performance - The closing price of *ST Green Kang was 40.54, reflecting a rise of 5.00% with a trading volume of 204,000 shares and a transaction value of 8.27 million yuan [1] - Other notable performers included Ruipu Biology with a closing price of 21.23, up 1.87%, and Biological Shares at 11.93, up 1.62% [1] - The overall trading volume and transaction values for various companies in the animal health sector were significant, with Biological Shares recording a transaction value of 954 million yuan [1] Group 2: Capital Flow - The animal health sector saw a net outflow of 57.68 million yuan from institutional investors, while retail investors contributed a net inflow of 60.01 million yuan [2] - The capital flow data indicates that *ST Green Kang had a net inflow of 1.42 million yuan from institutional investors, despite a net outflow from retail investors [3] - Other companies like Biological Shares and Ruipu Biology experienced significant net outflows from institutional investors, indicating a shift in investment sentiment [3]

Core Insights - The animal health sector experienced a 1.04% increase on November 11, with *ST Lvkang leading the gains [1] - The Shanghai Composite Index closed at 4002.76, down 0.39%, while the Shenzhen Component Index closed at 13289.0, down 1.03% [1] Stock Performance - *ST Lvkang (002868) closed at 35.02, up 5.01% with a trading volume of 1196 lots and a transaction value of 4.1884 million yuan [1] - Other notable performers included: - Qudongli (920275) at 10.36, up 4.65% [1] - Yongshun Biological (920729) at 9.97, up 2.15% [1] - Biological Shares (600201) at 10.63, up 1.24% [1] - Plai Ke (603566) at 14.42, up 1.19% [1] Capital Flow - The animal health sector saw a net outflow of 2.5437 million yuan from institutional investors and 7.7575 million yuan from speculative funds, while retail investors had a net inflow of 10.3012 million yuan [1] - Specific stock capital flows included: - Biological Shares (600201) with a net inflow of over 9.2092 million yuan from institutional investors [2] - *ST Lvkang (002868) had a net inflow of 1.1031 million yuan from retail investors [2] - Huayi Biological (603718) experienced a net outflow of 4.1338 million yuan from institutional investors [2]

关于公司控股股东一致行动人被裁定受理破产清算的进展 公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 重要内容提示： 1.截至本公告日，广东贤丰持有公司股份数量为 3,158,647 股，占公司总 股本的比例为 0.31%，享有公司表决权股份数量为 3,158,647 股，占公司有表决 权股份总数的比例为 0.38%。广东贤丰管理人拟定的《关于持有贤丰控股股份有 限公司 3,158,647 股股票的处置方案》已获得东莞市中级人民法院裁定认可。 证券代码：002141 证券简称：贤丰控股 公告编号：2025-079 2.广东贤丰持有的公司 3,158,647 股股票将通过京东司法拍卖平台整体打 包进行公开拍卖，开拍时间为 2025 年 11 月 12 日，起拍价单价为 3.91 元/股。 贤丰控股股份有限公司 2024 年 1 月，贤丰控股股份有限公司（简称"公司"、"贤丰控股"）收 到公司控股股东贤丰控股集团有限公司（简称"贤丰集团"）的一致行动人（全 资子公司）广东贤丰控股有限公司（简称"广东贤丰"或"广东贤丰公司"）的 通知，广东贤丰收到东莞市中级人民 ...

Core Viewpoint - The announcement indicates that Guangdong Xianfeng, a significant shareholder of Xianfeng Holdings, has been declared bankrupt, leading to the planned auction of its shares without affecting the company's control or daily operations [1] Summary by Relevant Sections Shareholder Status - Guangdong Xianfeng holds 3.1586 million shares, representing 0.31% of the total share capital of Xianfeng Holdings [1] Bankruptcy and Auction Details - The court has approved the stock disposal plan proposed by the administrator, allowing the 3.1586 million shares to be auctioned on the JD Judicial Auction platform [1] - The auction is scheduled to start on November 12, 2025, with a starting price of 3.91 yuan per share, totaling approximately 12.3503 million yuan [1] Impact on Company Operations - The disposal of shares will not result in a change of control for the company and will have no impact on its daily operations [1]

Core Insights - The animal health sector experienced a decline of 0.35% on November 3, with Reap Bio leading the losses [1] - The Shanghai Composite Index closed at 3976.52, up 0.55%, while the Shenzhen Component Index closed at 13404.06, up 0.19% [1] Stock Performance Summary - Hai Li Biological (603718) closed at 7.02, up 2.03% with a trading volume of 101,600 shares and a turnover of 70.93 million yuan [1] - Shen Lian Biological (688098) closed at 11.36, up 1.43% with a trading volume of 133,100 shares and a turnover of 150 million yuan [1] - Yong Shun Biological (920729) closed at 10.09, up 1.00% with a trading volume of 23,800 shares and a turnover of 24.09 million yuan [1] - The worst performer was Reap Bio (300119), which closed at 21.01, down 2.51% with a trading volume of 103,300 shares and a turnover of 219 million yuan [2] Capital Flow Analysis - The animal health sector saw a net outflow of 35.26 million yuan from institutional investors, while retail investors had a net inflow of 26.79 million yuan [2] - The main capital inflow was observed in Shen Lian Biological, with a net inflow of 4.03 million yuan from institutional investors [3] - Conversely, Reap Bio experienced a net outflow of 1.29 million yuan from institutional investors [3]

Core Viewpoint - The company, Xianfeng Holdings, announced that its shareholder, Shenzhen Ansheng Zhihua Investment Partnership (Limited Partnership), has committed to unconditionally and irrevocably waive all voting rights associated with its shares for a period of 12 months starting from October 31, 2025 [1] Summary by Category - **Shareholder Commitment** - Ansheng Zhihua has provided a commitment to waive all voting rights for its shares [1] - This waiver is effective for 12 months starting from October 31, 2025 [1]

Core Points - The company Xianfeng Holdings (002141.SZ) has received a commitment from its shareholder, Shenzhen Ansheng Zhihua Investment Partnership (Limited Partnership), to unconditionally and irrevocably waive all voting rights for a period of 12 months starting from October 31, 2025 [1] - During this period, Ansheng Zhihua will hold 0 shares with voting rights, while the controlling shareholder and its concerted parties collectively hold 117,310,647 shares with voting rights, accounting for 11.36% of the total voting shares of the company [1] - As of the date of the announcement, there has been no change in the control of the company [1]

证券代码：002141 证券简称：贤丰控股 公告编号：2025-078 贤丰控股股份有限公司 2.进展情况 收到《关于无条件且不可撤销放弃表决权的承诺》的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 深圳安盛致和投资合伙企业（有限合伙）承诺：自 2025 年 10 月 31 日起 12 个月内，继续无条件且不可撤销地放弃所持股份的全部表决权，期间其持有公 司有表决权的股份 0 股。控股股东及其一致行动人合计持有公司有表决权的股 份 117,310,647 股，占公司有表决权总股份的 11.36%，截至本公告日，公司控 制权尚未发生变更。 一、概述 贤丰控股股份有限公司（以下简称"公司"或"本公司"）于近日收到股东 深圳安盛致和投资合伙企业（有限合伙）（以下简称"安盛致和"或"本企业"） 出具的《关于无条件且不可撤销放弃表决权的承诺》，安盛致和承诺自 2025 年 10 月 31 日起 12 个月内，继续无条件且不可撤销地放弃所持股份的全部表决权。 二、放弃表决权的情况 1.前期情况 安盛致和前期通过京东拍卖平台获得公司股票 198,140, ...

Market Overview - The animal health sector experienced a decline of 2.79% on October 30, with Jinhe Biology leading the drop [1] - The Shanghai Composite Index closed at 3986.9, down 0.73%, while the Shenzhen Component Index closed at 13532.13, down 1.16% [1] Individual Stock Performance - Jinhe Biology (002688) closed at 6.25, down 7.13% with a trading volume of 578,000 shares and a transaction value of 367 million yuan [1] - Keqian Biology (688526) closed at 16.15, down 6.76% with a trading volume of 139,800 shares and a transaction value of 228 million yuan [1] - Maofeng Holdings (002141) closed at 3.92, down 5.08% with a trading volume of 461,300 shares and a transaction value of 18.3 million yuan [1] - Other notable declines include Dayu Biology (920970) down 2.69%, and Pulaike (603566) down 2.68% [1] Capital Flow Analysis - The animal health sector saw a net outflow of 84.7 million yuan from institutional investors, while retail investors experienced a net outflow of 16.5 million yuan [1] - Speculative funds recorded a net inflow of 101 million yuan [1] Detailed Capital Flow for Selected Stocks - Keqian Biology (688526) had a net inflow of 39.6 million yuan from institutional investors, while retail investors saw a net outflow of 60.9 million yuan [2] - Huisheng Biology (300871) experienced a net inflow of 18.3 million yuan from institutional investors, with a net outflow of 21.2 million yuan from retail investors [2] - Other stocks like Pulaike (603566) and Maofeng Holdings (002141) also reported significant net outflows from institutional investors [2]

第八届董事会第二十二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、董事会会议召开情况 1. 贤丰控股股份有限公司（以下简称"公司"）第八届董事会第二十二次 会议通知已提前以电话、邮件等方式发出。 2. 会议于 2025 年 10 月 29 日在子公司会议室以现场与电子通信（线上会议） 相结合的方式召开。 3. 会议应参与表决董事 7 人，实际参与表决董事 7 人（其中独立董事肖世 练先生、邓延昌先生、梁融先生以线上会议方式出席）。 4. 会议由公司董事长韩桃子女士主持。 5. 本次董事会会议的召开符合有关法律、行政法规、部门规章、规范性文 件和《公司章程》的规定。 二、董事会会议审议情况 证券代码：002141 证券简称：贤丰控股 公告编号：2025-076 贤丰控股股份有限公司 1.审议通过《2025 年三季度报告》 表决结果：以 7 票赞成、0 票反对、0 票弃权的表决结果，通过本议案。 三、备查文件 1.经与会董事签字并加盖董事会印章的董事会决议。 特此公告。 贤丰控股股份有限公司 董事会 2025 年 10 月 29 日 ...